A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice.
Open Med (Wars)
; 17(1): 53-60, 2022.
Article
in En
| MEDLINE
| ID: mdl-34993345
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Open Med (Wars)
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Poland